{"id":17940,"date":"2020-09-07T19:48:59","date_gmt":"2020-09-07T17:48:59","guid":{"rendered":"https:\/\/www.hollandbio.nl\/?p=17940"},"modified":"2020-09-07T19:49:00","modified_gmt":"2020-09-07T17:49:00","slug":"de-gezamenlijke-innovatie-van-market-acces","status":"publish","type":"post","link":"https:\/\/www.hollandbio.nl\/en\/nieuws\/de-gezamenlijke-innovatie-van-market-acces\/","title":{"rendered":"De gezamenlijke innovatie van Market Acces"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Om de innovatie in de gezondheidszorg te verzilveren die uit de Europese biotechsector voortkomt, moeten we ook voor de toegang tot behandelingen met innovatieve oplossingen komen, zo betoogt Anant Murthy, Vice President van Alnylam Pharmaceuticals. De enige manier om dat te doen, is door nadrukkelijk de samenwerking te zoeken met wetenschappers, pati\u00ebnten en beleidsmakers. Murthy stelt dat het gezamenlijk komen tot creatieve en flexibele oplossingen cruciaal is als we willen inspelen op de opkomst van nieuwe soorten behandelingen. Om het potentieel van de Europese biotech te verwezenlijken, is het nodig dat innovaties uit wetenschap, toegang voor pati\u00ebnten en overheidsbeleid hand in hand gaan. Wat HollandBIO betreft is <a href=\"https:\/\/news.alnylam.com\/perspectives\/articles\/innovation-market-access-european-patients-can-fully-experience-biotechs\"><strong>deze prikkelende visie<\/strong><\/a> het lezen waard!<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Om de innovatie in de gezondheidszorg te verzilveren die uit de Europese biotechsector voortkomt, moeten we ook voor de toegang tot behandelingen met innovatieve oplossingen komen, zo betoogt Anant Murthy, Vice President van Alnylam Pharmaceuticals. De enige manier om dat te doen, is door nadrukkelijk de samenwerking te zoeken met wetenschappers, pati\u00ebnten en beleidsmakers. Murthy [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[39],"tags":[],"class_list":["post-17940","post","type-post","status-publish","format-standard","hentry","category-gezondheid"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>De gezamenlijke innovatie van Market Acces - hollandbio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/de-gezamenlijke-innovatie-van-market-acces\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"De gezamenlijke innovatie van Market Acces - hollandbio\" \/>\n<meta property=\"og:description\" content=\"Om de innovatie in de gezondheidszorg te verzilveren die uit de Europese biotechsector voortkomt, moeten we ook voor de toegang tot behandelingen met innovatieve oplossingen komen, zo betoogt Anant Murthy, Vice President van Alnylam Pharmaceuticals. De enige manier om dat te doen, is door nadrukkelijk de samenwerking te zoeken met wetenschappers, pati\u00ebnten en beleidsmakers. Murthy [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/de-gezamenlijke-innovatie-van-market-acces\/\" \/>\n<meta property=\"og:site_name\" content=\"hollandbio\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-07T17:48:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-09-07T17:49:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"HollandBIO\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:site\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"HollandBIO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/de-gezamenlijke-innovatie-van-market-acces\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/de-gezamenlijke-innovatie-van-market-acces\\\/\"},\"author\":{\"name\":\"HollandBIO\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/48824449f08e494bb7ea02e1ff5dd6ea\"},\"headline\":\"De gezamenlijke innovatie van Market Acces\",\"datePublished\":\"2020-09-07T17:48:59+00:00\",\"dateModified\":\"2020-09-07T17:49:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/de-gezamenlijke-innovatie-van-market-acces\\\/\"},\"wordCount\":121,\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"articleSection\":[\"Gezondheid\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/de-gezamenlijke-innovatie-van-market-acces\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/de-gezamenlijke-innovatie-van-market-acces\\\/\",\"name\":\"De gezamenlijke innovatie van Market Acces - hollandbio\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\"},\"datePublished\":\"2020-09-07T17:48:59+00:00\",\"dateModified\":\"2020-09-07T17:49:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/de-gezamenlijke-innovatie-van-market-acces\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/de-gezamenlijke-innovatie-van-market-acces\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/de-gezamenlijke-innovatie-van-market-acces\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"De gezamenlijke innovatie van Market Acces\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"name\":\"hollandbio\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\",\"name\":\"hollandbio\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"width\":218.664,\"height\":29.659,\"caption\":\"hollandbio\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/hollandbio\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hollandbio\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/48824449f08e494bb7ea02e1ff5dd6ea\",\"name\":\"HollandBIO\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"De gezamenlijke innovatie van Market Acces - hollandbio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hollandbio.nl\/en\/nieuws\/de-gezamenlijke-innovatie-van-market-acces\/","og_locale":"en_US","og_type":"article","og_title":"De gezamenlijke innovatie van Market Acces - hollandbio","og_description":"Om de innovatie in de gezondheidszorg te verzilveren die uit de Europese biotechsector voortkomt, moeten we ook voor de toegang tot behandelingen met innovatieve oplossingen komen, zo betoogt Anant Murthy, Vice President van Alnylam Pharmaceuticals. De enige manier om dat te doen, is door nadrukkelijk de samenwerking te zoeken met wetenschappers, pati\u00ebnten en beleidsmakers. Murthy [&hellip;]","og_url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/de-gezamenlijke-innovatie-van-market-acces\/","og_site_name":"hollandbio","article_published_time":"2020-09-07T17:48:59+00:00","article_modified_time":"2020-09-07T17:49:00+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png","type":"image\/png"}],"author":"HollandBIO","twitter_card":"summary_large_image","twitter_creator":"@hollandbio","twitter_site":"@hollandbio","twitter_misc":{"Written by":"HollandBIO","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/de-gezamenlijke-innovatie-van-market-acces\/#article","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/de-gezamenlijke-innovatie-van-market-acces\/"},"author":{"name":"HollandBIO","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/48824449f08e494bb7ea02e1ff5dd6ea"},"headline":"De gezamenlijke innovatie van Market Acces","datePublished":"2020-09-07T17:48:59+00:00","dateModified":"2020-09-07T17:49:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/de-gezamenlijke-innovatie-van-market-acces\/"},"wordCount":121,"publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"articleSection":["Gezondheid"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/de-gezamenlijke-innovatie-van-market-acces\/","url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/de-gezamenlijke-innovatie-van-market-acces\/","name":"De gezamenlijke innovatie van Market Acces - hollandbio","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/#website"},"datePublished":"2020-09-07T17:48:59+00:00","dateModified":"2020-09-07T17:49:00+00:00","breadcrumb":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/de-gezamenlijke-innovatie-van-market-acces\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hollandbio.nl\/en\/nieuws\/de-gezamenlijke-innovatie-van-market-acces\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/de-gezamenlijke-innovatie-van-market-acces\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.hollandbio.nl\/en\/"},{"@type":"ListItem","position":2,"name":"De gezamenlijke innovatie van Market Acces"}]},{"@type":"WebSite","@id":"https:\/\/www.hollandbio.nl\/en\/#website","url":"https:\/\/www.hollandbio.nl\/en\/","name":"hollandbio","description":"","publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hollandbio.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.hollandbio.nl\/en\/#organization","name":"hollandbio","url":"https:\/\/www.hollandbio.nl\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","contentUrl":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","width":218.664,"height":29.659,"caption":"hollandbio"},"image":{"@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/hollandbio","https:\/\/www.linkedin.com\/company\/hollandbio\/"]},{"@type":"Person","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/48824449f08e494bb7ea02e1ff5dd6ea","name":"HollandBIO"}]}},"_links":{"self":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/17940","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/comments?post=17940"}],"version-history":[{"count":0,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/17940\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/media?parent=17940"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/categories?post=17940"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/tags?post=17940"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}